A detailed history of Fragasso Group Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Fragasso Group Inc. holds 17,914 shares of AZN stock, worth $1.17 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
17,914
Previous 17,789 0.7%
Holding current value
$1.17 Million
Previous $1.39 Million 0.58%
% of portfolio
0.11%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$76.67 - $87.62 $9,583 - $10,952
125 Added 0.7%
17,914 $1.4 Million
Q2 2024

Jul 08, 2024

BUY
$66.81 - $80.83 $6,814 - $8,244
102 Added 0.58%
17,789 $1.39 Million
Q1 2024

Apr 10, 2024

BUY
$61.03 - $69.57 $7,201 - $8,209
118 Added 0.67%
17,687 $1.2 Million
Q4 2023

Jan 08, 2024

SELL
$61.89 - $69.28 $13,120 - $14,687
-212 Reduced 1.19%
17,569 $1.18 Million
Q3 2023

Dec 06, 2023

BUY
$64.85 - $71.7 $3,761 - $4,158
58 Added 0.33%
17,781 $1.2 Million
Q2 2023

Jul 10, 2023

BUY
$69.91 - $75.81 $4,753 - $5,155
68 Added 0.39%
17,723 $1.27 Million
Q1 2023

Apr 13, 2023

BUY
$63.15 - $71.6 $30,880 - $35,012
489 Added 2.85%
17,655 $1.23 Million
Q4 2022

Jan 24, 2023

SELL
$54.21 - $70.44 $930,568 - $1.21 Million
-17,166 Closed
0 $0
Q4 2022

Jan 24, 2023

BUY
$54.21 - $70.44 $1,572 - $2,042
29 Added 0.17%
17,166 $0
Q1 2022

Apr 06, 2022

BUY
$55.72 - $67.12 $2,451 - $2,953
44 Added 0.26%
17,137 $1.14 Million
Q4 2021

Jan 19, 2022

SELL
$54.02 - $63.83 $756 - $893
-14 Reduced 0.08%
17,093 $996,000
Q3 2021

Oct 08, 2021

BUY
$55.56 - $60.79 $950,464 - $1.04 Million
17,107 New
17,107 $1.03 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Fragasso Group Inc. Portfolio

Follow Fragasso Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.